GA
ABVX

Goldstein Advisors’s Abivax ABVX Stock Holding History

Goldstein Advisors’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+1,598
New +$181K 0.02% 237

Other funds holding ABVX

SCS
Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
BMCM
Burns Matteson Capital Management Corning, New York $320M AUM 71.11% 1-Year Est. Return
QWM
QP Wealth Management Eatontown, New Jersey $70.1M AUM
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Goldstein Advisors's ABVX Position: Q2 2026 in Review

Goldstein Advisors opened a new position in Abivax (ABVX) in Q2 2026: 1,598 shares worth $213K. The stake represents 0.02% of the portfolio and ranks #237 among its holdings.

25 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Goldstein Advisors held 1,598 shares of Abivax worth $213K as of Q2 2026.
  • Abivax was a new Goldstein Advisors position in Q2 2026.
  • Abivax made up 0.02% of Goldstein Advisors's portfolio in Q2 2026, its #237 holding.
  • 25 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Goldstein Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.